• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Brief Report: Mortality After Loss to Follow-Up-A Linkage Study of People Living With HIV in Thailand and Malaysia.简要报告:随访丢失后的死亡率——泰国和马来西亚艾滋病毒感染者的关联研究。
J Acquir Immune Defic Syndr. 2022 Nov 1;91(3):290-295. doi: 10.1097/QAI.0000000000003067.
2
Predictors of the observed high prevalence of loss to follow-up in ART-experienced adult PLHIV: a retrospective longitudinal cohort study in the Tanga Region, Tanzania.观察到的接受抗逆转录病毒治疗的成年艾滋病毒感染者失访率高的预测因素:坦桑尼亚坦噶地区的一项回顾性纵向队列研究。
BMC Infect Dis. 2023 Feb 14;23(1):92. doi: 10.1186/s12879-023-08063-9.
3
Loss to follow-up and associated factors of patients in the National AIDS Program in Thailand.泰国国家艾滋病项目患者的失访情况及相关因素
Antivir Ther. 2018;23(6):529-538. doi: 10.3851/IMP3233.
4
Failure to return pillbox is a predictor of being lost to follow-up among people living with HIV on antiretroviral therapy in rural Tanzania.在坦桑尼亚农村地区接受抗逆转录病毒治疗的艾滋病毒感染者中,未归还药盒是失访的一个预测因素。
HIV Med. 2022 Jul;23(6):661-672. doi: 10.1111/hiv.13223. Epub 2021 Dec 28.
5
Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?在马里,开始抗逆转录病毒治疗后,艾滋病毒感染者失访后重新接受治疗:谁会回来接受治疗?
PLoS One. 2020 Sep 10;15(9):e0238687. doi: 10.1371/journal.pone.0238687. eCollection 2020.
6
Loss to follow-up and associated factors among adult people living with HIV at public health facilities in Wakiso district, Uganda: a retrospective cohort study.乌干达瓦基索地区公立卫生机构中艾滋病毒感染者成年人随访失访及相关因素:一项回顾性队列研究。
BMC Health Serv Res. 2019 Sep 4;19(1):628. doi: 10.1186/s12913-019-4474-6.
7
High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.2004年至2012年期间,在尼日利亚提供抗逆转录病毒治疗前护理的地点,艾滋病毒患者在抗逆转录病毒治疗前第一年的随访失访率很高。
PLoS One. 2017 Sep 1;12(9):e0183823. doi: 10.1371/journal.pone.0183823. eCollection 2017.
8
Self-transfers and factors associated with successful tracing among persons lost to follow-up from HIV care, Sheema District, Southwestern Uganda: retrospective medical records review, 2017-2021.自我转移与成功追踪到 HIV 护理中失访者的相关因素:回顾性病历审查,2017-2021 年,乌干达西南部谢马区。
AIDS Res Ther. 2022 Sep 20;19(1):44. doi: 10.1186/s12981-022-00471-2.
9
Long-term loss to follow-up in the TREAT Asia HIV Observational Database (TAHOD).在 TREAT Asia HIV 观察性数据库(TAHOD)中存在长期随访丢失的情况。
HIV Med. 2019 Aug;20(7):439-449. doi: 10.1111/hiv.12734. Epub 2019 Apr 12.
10
Tracing People Living With Human Immunodeficiency Virus Who Are Lost to Follow-up at Antiretroviral Therapy Programs in Southern Africa: A Sampling-Based Cohort Study in 6 Countries.追踪在南部非洲国家抗逆转录病毒治疗项目中失访的艾滋病毒感染者:6 个国家基于抽样的队列研究。
Clin Infect Dis. 2022 Jan 29;74(2):171-179. doi: 10.1093/cid/ciab428.

引用本文的文献

1
Improving estimators of HIV mortality and retention in care by linking clinical cohort data with national registries in Mexico.通过将临床队列数据与墨西哥国家登记处相链接来改进艾滋病毒死亡率和护理留存率的估计方法。
BMC Public Health. 2025 Jul 17;25(1):2489. doi: 10.1186/s12889-025-23542-1.
2
HIV Treatment Outcomes After 10 years on ART in the TREAT Asia Observational Database and Australian HIV Observational Database.在亚太地区治疗观察数据库和澳大利亚HIV观察数据库中接受抗逆转录病毒治疗10年后的HIV治疗结果。
J Acquir Immune Defic Syndr. 2024 Dec 15;97(5):460-470. doi: 10.1097/QAI.0000000000003515.
3
Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.在普遍的艾滋病病毒治疗指南下的长期艾滋病病毒护理结果:25 个国家的回顾性队列研究。
PLoS Med. 2024 Mar 18;21(3):e1004367. doi: 10.1371/journal.pmed.1004367. eCollection 2024 Mar.
4
Advanced HIV disease in Homa Bay County, Kenya: Characteristics of newly-diagnosed and antiretroviral therapy-experienced clients.肯尼亚霍马湾县的艾滋病晚期:新诊断和接受抗逆转录病毒治疗的患者的特征。
Medicine (Baltimore). 2023 Dec 22;102(51):e36716. doi: 10.1097/MD.0000000000036716.

简要报告:随访丢失后的死亡率——泰国和马来西亚艾滋病毒感染者的关联研究。

Brief Report: Mortality After Loss to Follow-Up-A Linkage Study of People Living With HIV in Thailand and Malaysia.

机构信息

The Kirby Institute, UNSW Sydney, NSW, Australia.

Hospital Sungai Buloh, Sungai Buloh, Malaysia.

出版信息

J Acquir Immune Defic Syndr. 2022 Nov 1;91(3):290-295. doi: 10.1097/QAI.0000000000003067.

DOI:10.1097/QAI.0000000000003067
PMID:35969472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9588686/
Abstract

BACKGROUND

Linkage studies have reported high rates of previously unascertained mortality among people living with HIV (PLHIV) who have been lost to follow-up (LTFU). We assessed survival outcomes among PLHIV who were LTFU in Thailand and Malaysia, through linkages to a national death registry or HIV database.

METHODS

Data linkages with the national death registry or national HIV database were conducted in 2020 on all PLHIV who met LTFU criteria while enrolled in care at participating HIV clinical sites. LTFU was defined as having no documented clinical contact in the previous year, excluding transfers and deaths. Survival time was analyzed using the Cox regression, stratified by site.

RESULTS

Data linkages were performed for 489 PLHIV who had been LTFU at sites in Malaysia (n = 2) and Thailand (n = 4). There were 151 (31%) deaths after being LTFU; the mortality rate was 4.89 per 100 person-years. Risk factors for mortality after being LTFU were older age [41-50 years: hazard ratio (HR) = 1.99, 95% confidence interval (CI): 1.08 to 3.68; and older than 50 years: HR = 4.93, 95% CI: 2.63 to 9.22; vs. age 30 years or younger]; receiving NRTI + PI (HR = 1.87, 95% CI: 1.22 to 2.85 vs. NRTI + NNRTI); positive hepatitis C antibody (HR = 2.25, 95% CI: 1.40 to 3.62); and having previous AIDS illness (HR = 1.45, 95% CI: 1.03 to 2.05). An improved survival was seen with a higher CD4 count (CD4 351-500 cells/µL: HR = 0.40, 95%CI: 0.21-0.76; and CD4 >500 cells/µL: HR = 0.43, 95%CI: 0.25-0.75; vs. CD4 ≤200 cells/µL).

CONCLUSIONS

Almost one-third of PLHIV who were LTFU in this cohort had died while out of care, emphasizing the importance of efforts to reengage PLHIV after they have been LTFU and ensure they have access to ongoing ART.

摘要

背景

失访(LTFU)的 HIV 感染者(PLHIV)的既往未确定死亡率在连锁研究中报告率较高。我们通过与国家死亡登记处或 HIV 数据库的链接,评估了泰国和马来西亚 LTFU 的 PLHIV 的生存结果。

方法

2020 年,对所有符合参加 HIV 临床站点护理时 LTFU 标准的 PLHIV 进行了与国家死亡登记处或国家 HIV 数据库的数据链接。LTFU 定义为在过去一年中没有记录的临床接触,不包括转介和死亡。使用 Cox 回归分析,按地点分层分析生存时间。

结果

对来自马来西亚(n=2)和泰国(n=4)的 LTFU 站点的 489 名 PLHIV 进行了数据链接。151 人(31%)在 LTFU 后死亡;死亡率为每 100 人年 4.89 人。LTFU 后死亡的危险因素包括年龄较大(41-50 岁:危险比(HR)=1.99,95%置信区间(CI):1.08 至 3.68;年龄大于 50 岁:HR=4.93,95%CI:2.63 至 9.22;与 30 岁或以下年龄);接受 NRTI+PI(HR=1.87,95%CI:1.22 至 2.85 与 NRTI+NNRTI);丙型肝炎抗体阳性(HR=2.25,95%CI:1.40 至 3.62);既往 AIDS 疾病(HR=1.45,95%CI:1.03 至 2.05)。CD4 计数较高时生存得到改善(CD4 351-500 个细胞/µL:HR=0.40,95%CI:0.21-0.76;CD4>500 个细胞/µL:HR=0.43,95%CI:0.25-0.75;与 CD4≤200 个细胞/µL 相比)。

结论

在该队列中,近三分之一的 LTFU 的 PLHIV 在脱离护理期间死亡,这强调了努力重新接触 LTFU 并确保他们能够获得持续的 ART 的重要性。